Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
33.00    -0.60 (-1.79%)
Bid:
33.00
Ask:
33.90
Spread: 0.90 (2.727%)
Market Cap: £24.23m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

5 Sep 2024 07:00

RNS Number : 9408C
Carclo plc
05 September 2024
 

05 September 2024

 

 

Carclo plc

 

Trading Update

Carclo plc, the leading global provider of high-precision components, offering comprehensive services from mould design, automation and production to assembly and printing, serving the life sciences, aerospace, optics and tech sectors, provides the following trading update ahead of our AGM.

Financial Performance

Our strategic focus on improving our balance sheet, enhancing asset utilisation, prioritising margin over volume, and maximising our global footprint continues to yield positive results.

The Group's trading performance year to date is in line with management's expectations. The US manufacturing rationalisation and improvement programme is on track. By focussing on cash management and leveraging stronger trading, we have further improved our net debt to uEBITDA ratio. This progress highlights our unwavering commitment to strengthening our financial health across all operations.

Our expectations for the FY25 full year and FY26 remain unchanged with margin expansion anticipated to continue as the Group starts to see the full benefits of the operational optimisation process, continuing our journey toward our strategic goals of 10% return on sales and 25% return on capital employed.

CTP Design & Engineering

Our CTP Design & Engineering division maintains its focus on asset revitalisation projects, which are crucial for driving the next phase of operational improvements. This strategic emphasis underlines our commitment to sustainably enhancing overall company performance and meeting the evolving needs of our clients. These efforts continue to strengthen Carclo's leadership position in the sector, with a clear vision for sustained, medium-term growth.

CTP US Manufacturing Solutions

The restructuring of our US operations is progressing ahead of schedule, as highlighted during our full-year results presentation. We have successfully completed final production runs in Tucson and are now fully focused on our operational turnaround strategy at our centralised facility in Pennsylvania.

New leadership teams in our specialised production cells are beginning to drive important improvements in asset utilisation and operational performance, which are leading to the expected enhancement in margins. These proactive measures position us well to address short-term challenges while keeping our eyes on the medium to long-term strategic goals.

CTP EMEA Manufacturing Solutions

Our CTP EMEA Manufacturing Solutions division continues to build on its strong performance as we focus on the next phase of operational improvement through material and process optimisation. Following the new operational setup in EMEA, the region has emerged even stronger, with lasting enhancements in operational efficiency.

We have achieved an optimal balance of efficiency and flexibility by establishing long-run operations in the UK and medium-flexible runs at our facility in the Czech Republic, which enables us to effectively meet the growing demands of the EMEA market.

Speciality Division

We have now combined our Aerospace and Specialised Optics businesses into our Speciality Division, dedicated to providing customised solutions for niche markets. Both sectors utilise a strong market position built on specialised precision components, ongoing innovation, and exceptional customer support. The Aerospace sector, in particular, has continued its growth trajectory, showcasing the success of our strategic initiatives and commitment to precision leadership. Our expanding precision machining capabilities have enhanced our product offerings, further strengthening Carclo's respected position in the aerospace industry. These accomplishments reflect our steadfast commitment to quality and innovation across all specialty operations.

Further details will be provided in our interim results for the six months ending 30 September 2024, which will be released later this year.

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc +44 (0) 20 8685 0500

Frank Doorenbosch Chief Executive Officer

Eric Hutchinson Chief Financial Officer

 

 

Forward-looking statements

 

Certain statements made in this announcement are forward-looking statements. Such statements are based on current expectations and are subject to a number of risks and uncertainties that could cause outcomes to differ materially from those expected.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFFEAFISIIS
Date   Source Headline
29th Jul 20113:12 pmRNSTotal Voting Rights
20th Jul 20112:06 pmRNSPerformance Share Plan
8th Jul 20114:03 pmRNSIssue of Equity
8th Jul 20113:57 pmRNSBlocklisting Interim Review
7th Jul 20112:13 pmRNSHolding(s) in Company
7th Jul 20112:11 pmRNSHolding(s) in Company
29th Jun 20111:50 pmRNSDirector/PDMR Shareholding
7th Jun 20117:00 amRNSFinal Results
7th Apr 20117:00 amRNSPre-close Trading Statement
28th Mar 20112:28 pmRNSHolding(s) in Company
9th Feb 20117:00 amRNSInterim Management Statement
28th Jan 201111:46 amRNSHolding(s) in Company
18th Jan 201111:02 amRNSHolding(s) in Company
17th Jan 20114:06 pmRNSHolding(s) in Company
13th Jan 20114:14 pmRNSHolding(s) in Company
16th Dec 20104:40 pmRNSSecond Price Monitoring Extn
16th Dec 20104:35 pmRNSPrice Monitoring Extension
7th Dec 20103:06 pmRNSDirector/PDMR Shareholding
23rd Nov 20107:00 amRNSHalf Yearly Report
10th Nov 20101:45 pmRNSHolding(s) in Company
8th Nov 20102:12 pmRNSHolding(s) in Company
3rd Nov 20101:58 pmRNSHolding(s) in Company
29th Oct 20104:40 pmRNSSecond Price Monitoring Extn
29th Oct 20104:35 pmRNSPrice Monitoring Extension
29th Oct 201012:07 pmRNSHolding(s) in Company
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:40 pmRNSSecond Price Monitoring Extn
21st Oct 20104:35 pmRNSPrice Monitoring Extension
21st Oct 20104:35 pmRNSPrice Monitoring Extension
4th Oct 20107:00 amRNSTrading Update
30th Sep 20109:40 amRNSTotal Voting Rights
8th Sep 20107:30 amRNSPerformance Share Plan
3rd Sep 20107:00 amRNSResult of AGM
26th Aug 20104:40 pmRNSSecond Price Monitoring Extn
26th Aug 20104:35 pmRNSPrice Monitoring Extension
18th Aug 20103:26 pmRNSBlock listing application
16th Aug 20107:00 amRNSInterim Management Statement
30th Jul 20108:15 amRNSTotal Voting Rights
30th Jul 20108:00 amRNSIssue of Equity
12th Jul 201011:55 amRNSPerformance Share Plan
12th Jul 201011:45 amRNSHolding(s) in Company
12th Jul 201011:35 amRNSHolding(s) in Company
5th Jul 201011:29 amRNSDirector/PDMR Shareholding
2nd Jul 20103:17 pmRNSTotal Voting Rights
2nd Jul 20103:12 pmRNSHolding(s) in Company
1st Jul 20109:19 amRNSIssue of Equity
25th Jun 201011:45 amRNSHolding(s) in Company
23rd Jun 20103:11 pmRNSHolding(s) in Company
15th Jun 201011:07 amRNSDirector/PDMR Shareholding
10th Jun 20109:25 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.